218 related articles for article (PubMed ID: 31790280)
1. Quality improvement in the management of people with epilepsy and intellectual disability: the development of clinical guidance.
Watkins L; O'Dwyer M; Kerr M; Scheepers M; Courtenay K; Shankar R
Expert Opin Pharmacother; 2020 Feb; 21(2):173-181. PubMed ID: 31790280
[No Abstract] [Full Text] [Related]
2. New anti-seizure medication for elderly epileptic patients.
Watkins L; O'Dwyer M; Shankar R
Expert Opin Pharmacother; 2019 Sep; 20(13):1601-1608. PubMed ID: 31112437
[No Abstract] [Full Text] [Related]
3. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
[TBL] [Abstract][Full Text] [Related]
4. Managing anti-epileptic drug treatment in adult patients with intellectual disability: a serious conundrum.
Doran Z; Shankar R; Keezer MR; Dale C; McLean B; Kerr MP; Devapriam J; Craig J; Sander JW
Eur J Neurol; 2016 Jul; 23(7):1152-7. PubMed ID: 27106363
[TBL] [Abstract][Full Text] [Related]
5. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological interventions for epilepsy in people with intellectual disabilities.
Beavis J; Kerr M; Marson AG
Cochrane Database Syst Rev; 2007 Jul; (3):CD005399. PubMed ID: 17636795
[TBL] [Abstract][Full Text] [Related]
7. Eslicarbazepine acetate response in intellectual disability population versus general population.
Allard J; Lawthom C; Henley W; Mclean B; Hudson S; Tittensor P; Rajakulendran S; Ellawela S; Pace A; Shankar R
Acta Neurol Scand; 2021 Mar; 143(3):256-260. PubMed ID: 33131083
[TBL] [Abstract][Full Text] [Related]
8. Perampanel in the general population and in people with intellectual disability: Differing responses.
Shankar R; Henley W; Wehner T; Wiggans C; McLean B; Pace A; Mohan M; Sadler M; Doran Z; Hudson S; Allard J; Sander JW
Seizure; 2017 Jul; 49():30-35. PubMed ID: 28552718
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptic drugs for seizure control in people with neurocysticercosis.
Sharma M; Singh T; Mathew A
Cochrane Database Syst Rev; 2015 Oct; (10):CD009027. PubMed ID: 26455722
[TBL] [Abstract][Full Text] [Related]
10. Current state of the union of epilepsy care in the United States: Antiepileptic drugs - An introduction to the Connectors Project.
Sirven JI; Shafer PO; Kalilani L; Wild I; Fishman J; Owens S
Epilepsy Behav; 2018 Mar; 80():98-103. PubMed ID: 29414565
[TBL] [Abstract][Full Text] [Related]
11. Antiepileptic drug therapy.
Podell M
Clin Tech Small Anim Pract; 1998 Aug; 13(3):185-92. PubMed ID: 9775509
[TBL] [Abstract][Full Text] [Related]
12. Seizure freedom with different therapeutic regimens in intellectually disabled epileptic patients.
Huber B; Hauser I; Horstmann V; Jokeit G; Liem S; Meinert T; Robertson E; Schorlemmer H; Wagner W; Seidel M
Seizure; 2005 Sep; 14(6):381-6. PubMed ID: 15985376
[TBL] [Abstract][Full Text] [Related]
13. Long-term course of epilepsy in a large cohort of intellectually disabled patients.
Huber B; Hauser I; Horstmann V; Jokeit G; Liem S; May T; Meinert T; Robertson E; Schorlemmer H; Wagner W; Seidel M
Seizure; 2007 Jan; 16(1):35-42. PubMed ID: 17157535
[TBL] [Abstract][Full Text] [Related]
14. Challenging behavior in adults with epilepsy and intellectual disability: An analysis of epilepsy characteristics.
van Ool JS; Snoeijen-Schouwenaars FM; Tan IY; Jurgen Schelhaas H; Aldenkamp AP; Hendriksen JGM
Epilepsy Behav; 2018 Sep; 86():72-78. PubMed ID: 30153936
[TBL] [Abstract][Full Text] [Related]
15. Antiepileptic drug use and epileptic seizures in nursing home residents in the Province of Pavia, Italy: A reappraisal 12 years after a first survey.
Galimberti CA; Tartara E; Dispenza S; Marchese D; Bonizzoni E; Perucca E;
Epilepsy Res; 2016 Jan; 119():41-8. PubMed ID: 26656178
[TBL] [Abstract][Full Text] [Related]
16. European perspective of perampanel response in people with Intellectual Disability.
Allard J; Henley W; Snoeijen-Schouwenaars F; van Ool J; Tan I; Jurgen Schelhaas H; Majoie MHJM; Hudson S; McLean B; Shankar R
Acta Neurol Scand; 2020 Sep; 142(3):255-259. PubMed ID: 32383205
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapeutic strategies for treating epilepsy in patients with Alzheimer's disease.
Cretin B
Expert Opin Pharmacother; 2018 Aug; 19(11):1201-1209. PubMed ID: 30009650
[TBL] [Abstract][Full Text] [Related]
18. The benefits of antiepileptic drug (AED) blood level monitoring to complement clinical management of people with epilepsy.
Stepanova D; Beran RG
Epilepsy Behav; 2015 Jan; 42():7-9. PubMed ID: 25499154
[TBL] [Abstract][Full Text] [Related]
19. Drug Treatment of Seizures and Epilepsy in Newborns and Children.
Dang LT; Silverstein FS
Pediatr Clin North Am; 2017 Dec; 64(6):1291-1308. PubMed ID: 29173786
[TBL] [Abstract][Full Text] [Related]
20. Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study.
Sun JJ; Perera B; Henley W; Angus-Leppan H; Sawhney I; Watkins L; Purandare KN; Eyeoyibo M; Scheepers M; Lines G; Winterhalder R; Ashby S; De Silva R; Miller J; Philpott DE; Ashwin C; Howkins J; Slater H; Medhurst D; Shankar R
J Neurol; 2022 May; 269(5):2750-2760. PubMed ID: 35067759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
